BOSWELLIN® SUPER : an extract of Boswellia Serrata clinically proven effective against joint pain
Boswellia serrata resin is particularly indicated for joint comfort thanks to its anti-inflammatory properties, known for thousands of years in Ayurvedic medicine.
Boswellin® Super is a standardised extract obtained from the resin exudate gum of the Boswellia Serrata tree.
This extract contains 75 mg of boswellic acids, including 30 mg of AKBA*, active ingredients of interest in inflammation management.
Boswellic acids and AKBA* act on inflammation by:
- Inhibiting the action of the enzyme 5-lipoxygenase
- Inhibiting the activity of cycloxygenase-1
- Selective inhibition of the NF-κB activation mechanism
- Inhibition of leukotriene-mediated inflammatory pathways
- Suppression of pro-inflammatory cytokines
Through this mode of action, Boswellin® Super helps to limit the progression of inflammatory and auto-immune diseases such as arthritis.
A double-blind, placebo-controlled clinical study of 48 people diagnosed with osteoarthritis of the knee was conducted for 120 days.
Symptoms associated with osteoarthritis were assessed using a participant questionnaire (WOMAC**).
Symptoms of arthritis diminished progressively from 30 days up to 120 days.
At the same time, improvement in symptoms was demonstrated by X-ray images.
After 120 days, an improvement in the inter-articular space was demonstrated, as well as a reduction in osteocytes.
(1) Majeed et al, 2019, Phytotherapy research, 33:1457-1468
*AKBA : 3-O-acetyl-11-keto-β-boswellic acid
**WOMAC (Western Ontario and Mc Master Universities Arthritis Index) mesure la douleur articulaire et la fonction articulaire dans la vie quotidienne.
Boswellin® is a trademark of Sabinsa Europe GmbH.